MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$3,140K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Change in fair value of financia...
Loss on debt extinguishment
Borrowings under short-term debt...
Others
Negative Cash Flow Breakdown
Net loss
Trade accounts receivable
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-11,036
-5,465
2,788
-1,569
Gain on change in accounting estimates on contingent royalty liability
-
-
0
1,933
Loss on debt extinguishment
-2,192
-
-
-
Change in fair value of financial instruments
-5,745
-162
131
-1,845
Inventory write-down for excess & obsolescence
118
192
834
0
Loss on contingent liability
61
58
29
0
Stock-based compensation
0
15
42
23
Depreciation
4
4
5
4
Amortization of intangible asset
14
75
89
80
Noncash interest expense
626
614
606
595
Noncash right-of-use asset amortization
32
32
13
34
Net loss on disposal or impairment of property and equipment
-
-
0
0
Gain on accounts payable and accrued expenses settlements
-
-
18
11
Trade accounts receivable
1,937
-11,920
8,045
-499
Inventories
265
761
-25
-222
Prepaid and other assets
-83
130
144
-423
Accounts payable
29
-1,605
1,547
-656
Accrued expenses and other liabilities
600
-1,636
3,452
502
Accrued compensation
682
-1,092
-1,022
360
Contingent liabilities
-56
-50
-24
-50
Operating lease liabilities
-32
-32
-15
-32
Net restricted cash and cash equivalents used in operating activities
-3,140
2,301
31
336
Payments related to asset acquisition
-
-
-
0
Payments related to intangible asset acquisition
-
-
57
-
Purchases of property and equipment
0
2
3
0
Net restricted cash and cash equivalents used in investing activities
0
-2
-3
0
Proceeds from issuance of aditxt notes related party
-
-
0
0
Borrowings under short-term debt and notes carried at fair value
1,068
-
0
0
Payments under short-term debt and notes carried at fair value
22
498
278
244
Cash paid for financing costs
-
-
12
-
Net restricted cash and cash equivalents provided by financing activities
1,046
-498
-290
-244
Net change in restricted cash and cash equivalents
-2,094
1,801
-262
92
Restricted cash and cash equivalents, beginning of period
2,379
578
840
741
Restricted cash and cash equivalents, end of period
285
2,379
578
840
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Borrowings under
short-term debt and notes ...
$1,068K
(178.85%↑ Y/Y)
Net restricted cash
and cash...
$1,046K
(-56.87%↓ Y/Y)
Canceled cashflow
$22K
Net change in
restricted cash and cash...
-$2,094K
(-30014.29%↓ Y/Y)
Canceled cashflow
$1,046K
Change in fair value of
financial instruments
-$5,745K
(-523.99%↓ Y/Y)
Loss on debt
extinguishment
-$2,192K
Accrued compensation
$682K
(378.37%↑ Y/Y)
Noncash interest
expense
$626K
(-46.27%↓ Y/Y)
Accrued expenses and
other liabilities
$600K
(16.73%↑ Y/Y)
Inventory write-down for
excess & obsolescence
$118K
(-33.71%↓ Y/Y)
Prepaid and other assets
-$83K
(-7.79%↓ Y/Y)
Loss on contingent
liability
$61K
(144.00%↑ Y/Y)
Noncash right-of-use
asset amortization
$32K
(-47.54%↓ Y/Y)
Accounts payable
$29K
(104.09%↑ Y/Y)
Amortization of intangible
asset
$14K
(-95.76%↓ Y/Y)
Depreciation
$4K
(-60.00%↓ Y/Y)
Payments under
short-term debt and notes ...
$22K
(-94.26%↓ Y/Y)
Net restricted cash
and cash...
-$3,140K
(-33.11%↓ Y/Y)
Canceled cashflow
$10,186K
Net loss
-$11,036K
(-1232.85%↓ Y/Y)
Trade accounts
receivable
$1,937K
(139.55%↑ Y/Y)
Inventories
$265K
(-47.73%↓ Y/Y)
Contingent liabilities
-$56K
(86.82%↑ Y/Y)
Operating lease
liabilities
-$32K
(48.39%↑ Y/Y)
Buy us a coffee
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)